In technology-driven mergers and acquisitions, a Freedom to Operate (FTO) opinion is one of the few diligence instruments that directly addresses catastrophic downside risk. Unlike patent portfolio reviews, which assess offensive strength, an FTO for M&A evaluates whether the target’s existing and planned products can be commercialized without infringing enforceable third-party patent rights.
An FTO opinion does not guarantee safety. It provides a structured, evidence-based assessment of infringement exposure based on defined product configurations, jurisdictions, claim interpretation assumptions, and a fixed search cut-off date. Used correctly, it enables rational valuation, targeted indemnities, and executable mitigation strategies. Used superficially, it becomes a false comfort document that collapses under buyer counsel scrutiny.
What an FTO Opinion Proves in an Acquisition Context
FTO vs Patentability vs Validity and Why Buyers Separate Them
Three legally distinct questions are often conflated during early deal discussions.
Patentability asks whether the target’s invention is new and non-obvious under applicable statutes, such as Sections 2 and 3 of the Indian Patents Act, 1970. This affects the target’s ability to obtain patents and defend a future moat.
Validity asks whether a granted patent, whether owned by the target or a third party, can survive challenge. This is uncertain by nature and usually resolved only through opposition or litigation.
Freedom to Operate asks whether the target’s actual product or process, as implemented and sold, likely falls within the scope of one or more in-force third-party claims in relevant jurisdictions.
From a buyer’s perspective, patentability is upside optionality. FTO is downside containment. A company can hold strong patents and still be blocked from commercialization by broader foundational patents held by incumbents.
The Product-to-Claims Test Applied in M&A Due Diligence
M&A-grade FTO analysis is not technology-to-technology comparison. It is a product-to-claims exercise.
Buyer counsel evaluates:
· What exact products, SKUs, or deployments generate revenue
· Which claim sets are active and enforceable in relevant markets
· Whether each material claim limitation is present, absent, or uncertain in the product
FTO opinions fail most often because the target describes intent or architecture at a high level rather than how the product is actually configured, deployed, and monetized.
FTO as a Risk Allocation Tool Rather Than a Non-Infringement Guarantee
Even the strongest FTO opinion cannot eliminate risk entirely. Claims may be construed differently by courts, continuation applications may issue after signing, and competitors may assert patents strategically following deal announcements.
The commercial purpose of an FTO opinion is therefore risk allocation. It informs whether risk should be absorbed into price, shifted via indemnities, neutralized through licensing or design-around, or isolated through deal structure.
Legal Standards and Jurisdictional Nuances of Infringement Analysis
India: Claim Scope, Pendency, and Enforcement Realities
In India, infringement is inferred from the rights granted under Section 48 of the Patents Act, 1970, with defenses available under Section 107.
Key complications for FTO analysis include:
· Heavy reliance on pending applications, particularly in software and electronics
· Material claim amendments during FER responses and hearings
· Fact-intensive injunction analysis balancing market impact and convenience
Based on current IPO examination practice, FTO opinions must clearly distinguish granted claims from published but pending claims and explicitly qualify future risk arising from prosecution uncertainty.
United States: Willfulness, Opinion Counsel, and Privilege Strategy
Under 35 U.S.C. § 271, infringement exposure in the US carries heightened risk due to willfulness and enhanced damages. Post-Halo, the presence of a competent, timely FTO opinion can mitigate willfulness allegations, but only if product facts are accurately captured.
In M&A contexts, buyers examine:
· Whether the opinion was obtained after awareness of risk
· Whether it was prepared by independent counsel
· Whether privilege will be preserved or waived post-closing
A weak or poorly scoped opinion can increase exposure by evidencing knowledge without adequate mitigation.
Europe: Injunction Leverage, UPC Risk, and Country-Specific Exposure
In Europe, injunction risk often outweighs damages exposure. The emergence of the Unified Patent Court introduces multi-jurisdictional enforcement risk for opted-in patents.
An EU-focused FTO must separate:
· EPO-granted patents and national validations
· UPC-relevant exposure
· Market-specific sales and deployment footprints
When a No-Opinion or Inconclusive Opinion Is the Correct Outcome
In M&A, pressure to deliver certainty can produce unreliable conclusions. A no-opinion outcome is appropriate where:
· Product specifications are unstable
· Claim scope of pending applications is unpredictable
· Factual evidence cannot support claim mapping
In such cases, disciplined mitigation planning is preferable to artificial certainty.
Procedural Mechanics of an M&A-Grade FTO Search
Defining Product Boundaries and Feature Mapping
An FTO search begins with a defensible product definition. For software and platforms, this includes:
· Feature flags and optional modules
· Deployment variants and integrations
· Third-party dependencies
· Revenue-critical configurations
Without this granularity, claim mapping becomes speculative.
Jurisdiction and Market Mapping
FTO scope must track where infringement can legally occur:
· Manufacture, sale, offer for sale, import, or use
· Server locations for system and method claims
· Customer deployment geography
Single-jurisdiction FTOs for multi-market products are treated as partial diligence.
Patent Set Construction and Continuation Risk
An M&A-grade search must include:
· Active claim sets of granted patents
· Family members with divergent claims
· US continuations and divisionals
· Assertion behaviour of key assignees
Timing Traps and Search Cut-Off Limitations
FTO opinions are time-bound. They must disclose:
· Search cut-off date
· Monitoring triggers until closing
· Assumptions regarding late-issuing patents
What Strong FTO Work Product Looks Like in a Data Room
Mandatory Contents of a Buyer-Facing FTO Package
A defensible FTO package includes:
· Databases and jurisdictions searched
· Search strategy and classification logic
· Cut-off date and exclusions
· Product assumptions and factual inputs
Opinions lacking this transparency are routinely discounted.
Claim Charts That Survive Buyer Counsel Review
Effective claim charts:
· Map each limitation to concrete product evidence
· Separate absent, present, and uncertain elements
· Avoid conclusory language
· Flag evidentiary gaps explicitly
Risk Grading Frameworks
Risk grading should be rule-based and consistent, factoring:
· Claim breadth
· Enforcement likelihood
· Design-around feasibility
· Business criticality
Supporting Artefacts and Mitigation Notes
Mature data rooms include:
· Non-infringement rationales
· Design-around feasibility notes
· Existing licenses and settlement history
· Monitoring plans for pending applications
Strategic Management of Identified Infringement Risks
Design-Arounds and Technical Workarounds
Design-around feasibility depends on:
· Whether at least one claim element can be removed
· Cost and performance impact
· Time-to-market implications
Every design-around requires follow-up FTO validation.
Invalidation and Opposition Strategies
Where patents appear weak, acquirers may pursue:
· Pre-grant or post-grant opposition in India
· Revocation under Section 64
· IPR proceedings before the PTAB in the US
Invalidation is often cheaper than licensing but increases visibility and retaliation risk.
Licensing vs Litigation Cost Trade-Offs
Licensing offers certainty but creates long-term royalty drag. Invalidation offers freedom but carries uncertainty and public exposure. Deal strategy depends on market criticality and time sensitivity.
Impact of FTO Findings on Deal Structuring
Price Adjustments, Earnouts, and Holdbacks
Identified FTO risks are reflected through:
· Valuation haircuts
· Milestone-linked earnouts
· Escrow holdbacks tied to risk resolution
Indemnities and Escrow Structures
High-risk patents often trigger special indemnities backed by escrow funds. These are separate from general IP representations.
Closing Conditions and Covenants
Buyers may require:
· Pre-closing license execution
· Completion of design-arounds
· Covenants restricting risk-increasing product changes
Asset Deals vs Stock Deals
Where infringement risk is uncertain, asset deals allow selective transfer of clean IP while isolating liabilities, subject to license assignability constraints.
Sector-Specific FTO Challenges
Life Sciences and Biosimilars
FTO in pharma focuses on API, formulation, method-of-use, and dosing patents, along with patent term extensions and regulatory linkages.
Electronics, Software, and Standard Essential Patents
SEPs introduce royalty exposure rather than injunction risk. Acquirers must verify FRAND licenses and past damages exposure, particularly in 5G and IoT deals.
Frequently asked questions (FAQs)
· FTO for M&A assesses infringement risk tied to real products and markets, not abstract technology.
· An FTO opinion reduces but does not eliminate litigation risk.
· Buyer reliance on seller opinions depends on scope, independence, and evidentiary quality.
· Pending applications must be treated as monitorable future risk.
· Product definition errors are the most common FTO failure point.
· US FTO opinions intersect directly with willfulness analysis.
· Deals can proceed with known risk if mitigation is structured.
· Patent ownership does not imply freedom to operate.
· FTO refreshes are common between signing and closing.
· Data rooms should include claim charts, assumptions, and mitigation notes.